Article
RAS mutations in thyroid cancer.
The oncologist - 1 Jan 2013
Howell Gina M, Hodak Steven P, Yip Linwah
Abstract excerpt
In recent years, our understanding of the genetic alterations underlying thyroid oncogenesis has greatly expanded. The use of molecular markers, including RAS, in the management of thyroid carcinoma is also increasing. This review summarizes the current literature surrounding RAS and discusses its potential as a diagnostic and prognostic indicator in the management of thyroid cancer.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
